Cloning Vector pBR322: Structure, Mechanism, and Applications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Cloning Vector pBR322

A cloning vector is a small, self-replicating DNA molecule—typically a plasmid, bacteriophage, or cosmid—used to carry and propagate a foreign DNA fragment inside a host organism. The essential features of any cloning vector include an origin of replication, a selectable marker, and at least one unique restriction site for inserting foreign DNA. For a broader overview of these requirements, see Features of Cloning Vector.

pBR322 is one of the most historically important plasmid cloning vectors in molecular biology. Constructed in 1977 by Francisco Bolivar and Raymond Rodriguez, pBR322 was among the first plasmids specifically engineered for cloning purposes. Its name encodes its provenance: "p" denotes plasmid, "B" and "R" refer to Bolivar and Rodriguez, and "322" is the numerical identifier of the construct in their series.

pBR322 is a double-stranded, circular DNA plasmid of 4,361 base pairs (bp). It was derived from naturally occurring plasmids through a series of recombination events, combining elements from pMB1 (origin of replication), pSC101 (tetracycline resistance), and a transposon-derived ampicillin resistance gene. Despite being superseded by more sophisticated vectors for many applications, pBR322 remains a cornerstone in the teaching of recombinant DNA technology and is still used in research contexts where its moderate copy number and dual antibiotic selection are advantageous.

The significance of pBR322 lies in its design: it introduced the concept of a compact, well-characterized plasmid with multiple unique restriction sites within antibiotic resistance genes, enabling the detection of recombinant clones through insertional inactivation. This design principle underpins virtually all modern cloning vectors.

Structure and Genetic Elements of pBR322

The pBR322 plasmid is 4,361 bp in size and contains three primary genetic elements: the origin of replication (ori), the ampicillin resistance gene (bla), and the tetracycline resistance gene (tet). The complete nucleotide sequence of pBR322 was determined in 1979, making it one of the first plasmids to be fully sequenced.

The physical map of pBR322 is organized as follows:

Origin of Replication (ori)

The origin of replication in pBR322 is derived from the pMB1 plasmid, a close relative of the ColE1 plasmid. This ori region contains the essential elements for initiation of replication: the RNA II promoter, the RNA I promoter, and the origin itself where DNA synthesis begins.

The pMB1/ColE1-type ori is a 768-bp region that functions through a primer-dependent mechanism. Replication initiates when RNA II, a transcript synthesized from a promoter upstream of the origin, forms a persistent RNA-DNA hybrid with the template strand. This hybrid is then processed by RNase H, which cleaves the RNA primer, allowing DNA polymerase I to extend it and initiate leading-strand synthesis. The mechanism is detailed further in the replication section below.

Antibiotic Resistance Genes

pBR322 carries two antibiotic resistance genes, each providing a distinct selectable marker:

**Ampicillin resistance (bla gene):** The bla gene encodes β-lactamase (also called TEM-1 β-lactamase), a 286-amino-acid periplasmic enzyme that hydrolyzes the β-lactam ring of ampicillin and related penicillins. This hydrolysis inactivates the antibiotic, rendering the bacterial cell resistant. The bla gene in pBR322 is under the control of its native promoter and includes a signal peptide that directs the enzyme to the periplasm, where it can encounter and degrade extracellular ampicillin.

**Tetracycline resistance (tet gene):** The tet gene in pBR322 is a composite of two overlapping coding sequences: tetA, which encodes an efflux pump (TetA) that actively transports tetracycline out of the cell, and tetR, which encodes a repressor protein (TetR) that regulates tetA expression. In the absence of tetracycline, TetR binds to the operator and represses transcription of tetA. When tetracycline enters the cell, it binds TetR, causing a conformational change that releases the repressor from the operator, allowing tetA transcription and efflux pump production.

Multiple Cloning Sites and Unique Restriction Sites

pBR322 does not contain a synthetic multiple cloning site (MCS) as found in modern vectors. Instead, it possesses a set of unique restriction sites distributed across the plasmid. The most commonly used unique sites include:

• **Within the tet gene:** *Bam*HI (position 375), *Sal*I (position 651), *Sph*I (position 566), and *Eco*RV (position 187)
• **Within the bla gene:** *Pst*I (position 3609), *Sca*I (position 3846), and *Pvu*I (position 3735)
• Outside both resistance genes: *Eco*RI (position 4361/0), *Cla*I (position 23), *Hind*III (position 29), *Bam*HI is also present at position 375 within tet, and *Nhe*I (position 229)

The strategic placement of unique restriction sites within the antibiotic resistance genes is the key design feature that enables insertional inactivation screening. If a foreign DNA fragment is inserted into the *Bam*HI site, for example, the tet gene is disrupted, and the recombinant plasmid confers only ampicillin resistance, not tetracycline resistance. This dual-marker system allows for straightforward identification of recombinant clones.

Replication and Copy Number Control

Rolling Circle vs. Theta Replication

pBR322 replicates via the theta mechanism, not rolling circle replication. Theta replication is bidirectional or unidirectional and involves the formation of a replication bubble that expands around the circular plasmid. In pBR322, replication is unidirectional, proceeding clockwise from the origin.

The initiation of theta replication in pBR322 involves the following steps:

1. RNA II (a 555-nucleotide transcript) is synthesized from the RNA II promoter, located approximately 555 bp upstream of the origin.
2. RNA II forms a stable RNA-DNA hybrid with the template DNA at the origin region, creating a "pre-priming" complex.
3. RNase H recognizes this RNA-DNA hybrid and cleaves the RNA, generating a free 3'-OH group.
4. DNA polymerase I extends from this 3'-OH, synthesizing the leading strand.
5. DNA polymerase III takes over for processive synthesis, and the replication fork proceeds around the plasmid.
6. Termination occurs when the fork reaches the termination site, and the two daughter molecules are separated by topoisomerases.

Role of Rop Protein

The rop gene (repressor of primer), also called rom, encodes a 63-amino-acid protein that forms a dimer and binds to the RNA I-RNA II complex. Rop acts as a negative regulator of replication by stabilizing the interaction between RNA I and RNA II.

RNA I is a 108-nucleotide antisense RNA transcribed from the complementary strand of the RNA II promoter region. RNA I is complementary to the 5' end of RNA II. When RNA I binds to RNA II, it induces a conformational change in RNA II that prevents it from forming the stable RNA-DNA hybrid required for replication initiation.

Rop protein enhances this inhibitory effect by binding to the RNA I-RNA II duplex and stabilizing it. The result is a reduced frequency of replication initiation. Plasmids with a functional rop gene maintain a copy number of approximately 15–20 per cell; plasmids with a mutated or deleted rop gene (such as pUC19) can reach copy numbers of 500–700 per cell.

Copy Number and Its Implications

The copy number of pBR322 in E. coli is approximately 15–20 copies per chromosome equivalent under standard growth conditions. This moderate copy number has several practical implications:

• Moderate gene dosage: For cloning experiments, 15–20 copies per cell provides sufficient DNA yield for restriction analysis and sequencing without overburdening the host cell's metabolism.
• Compatibility with certain genes: Some genes are toxic when overexpressed; the moderate copy number of pBR322 allows propagation of such genes more readily than high-copy vectors.
• Stability: Lower copy number generally correlates with greater structural stability, as high-copy plasmids are more prone to recombination and deletion events.
• Yield considerations: Plasmid DNA yields from pBR322 cultures are typically 0.2–1 μg per mL of culture in rich medium, which is sufficient for most analytical purposes but lower than high-copy vectors.

Copy number is also affected by growth conditions. In minimal medium, the copy number decreases; in rich medium with amino acid supplementation, it increases. Chloramphenicol amplification (adding 170 μg/mL chloramphenicol to inhibit protein synthesis) can increase the copy number of pBR322 to several thousand per cell, as replication continues while cell division is halted.

Selectable Markers and Their Mechanism

Ampicillin Resistance (bla gene)

The bla gene in pBR322 encodes TEM-1 β-lactamase, a 286-amino-acid enzyme with a molecular weight of approximately 29 kDa. The enzyme is synthesized as a precursor with a 23-amino-acid signal peptide that directs it through the inner membrane into the periplasm.

The mechanism of ampicillin resistance involves:

1. Enzyme secretion: The β-lactamase is exported to the periplasm, where it is freely accessible to antibiotics diffusing through the outer membrane porins.
2. β-lactam ring hydrolysis: The enzyme catalyzes the hydrolysis of the amide bond in the β-lactam ring of ampicillin. This ring is essential for the antibiotic's ability to inhibit transpeptidases (penicillin-binding proteins) involved in peptidoglycan cross-linking.
3. Antibiotic inactivation: Once the β-lactam ring is opened, ampicillin can no longer bind to penicillin-binding proteins, and the antibiotic is rendered inert.

The bla gene is constitutively expressed from its native promoter. In laboratory selection, ampicillin is typically used at 50–100 μg/mL in LB agar or broth. A critical practical consideration is that β-lactamase is secreted into the culture medium, where it can degrade ampicillin around the colony. This leads to the formation of "satellite colonies"—non-resistant bacteria that grow in the zone of inactivated antibiotic surrounding resistant colonies. This phenomenon is discussed further in the troubleshooting section.

Tetracycline Resistance (tet gene)

The tet gene in pBR322 is a two-gene system: tetR and tetA. The tetR gene encodes the TetR repressor (23.4 kDa), and the tetA gene encodes the TetA efflux pump (42 kDa). The two genes are transcribed divergently from a shared operator/promoter region.

The mechanism of tetracycline resistance:

1. Induction: Tetracycline enters the cell and binds to the TetR repressor with high affinity (Kd ≈ 10⁻⁹ M). The antibiotic-Mg²⁺ complex binds TetR, causing a conformational change that reduces TetR's affinity for the operator DNA.
2. Derepression: When TetR dissociates from the operator, transcription of both tetR and tetA is activated.
3. Efflux: The TetA protein is an inner membrane antiporter that exchanges a tetracycline-Mg²⁺ complex for a proton. This active transport removes tetracycline from the cytoplasm, reducing intracellular antibiotic concentration below inhibitory levels.

Tetracycline is used at 10–15 μg/mL in laboratory media. Unlike ampicillin, tetracycline is stable in the medium and is not degraded by the resistance mechanism, so satellite colonies are not observed with tetracycline selection.

Insertional Inactivation

Insertional inactivation is the process by which the insertion of a foreign DNA fragment into a gene disrupts that gene's function. In pBR322, this is exploited for screening recombinant clones.

The procedure works as follows:

1. A foreign DNA fragment is ligated into a unique restriction site located within one of the antibiotic resistance genes (e.g., *Bam*HI in the tet gene).
2. The ligation mixture is transformed into E. coli.
3. Transformants are first selected on ampicillin-containing medium. All transformants (both recombinant and non-recombinant) will grow because the bla gene is intact.
4. Individual ampicillin-resistant colonies are then replica-plated onto tetracycline-containing medium.
5. Colonies that grow on ampicillin but not on tetracycline contain recombinant plasmids with the insert in the tet gene. Colonies that grow on both antibiotics contain either non-recombinant pBR322 or recombinant plasmids with the insert elsewhere (outside the tet gene).

This dual-selection strategy is the defining feature of pBR322 and was the standard approach for clone screening before the advent of blue-white screening with lacZ-based vectors.

Cloning Procedure Using pBR322

Restriction Digestion and Ligation

The cloning procedure using pBR322 follows a standard workflow:

1. Prepare vector DNA: Isolate pBR322 from E. coli using alkaline lysis or a commercial plasmid purification kit. Quantify the DNA by spectrophotometry (A₂₆₀) or gel electrophoresis.

1. Digest vector and insert: Set up separate restriction digests for pBR322 and the foreign DNA fragment. A typical reaction contains:
2. 1–2 μg plasmid DNA
3. 10 units of restriction enzyme per μg DNA
4. 1× appropriate restriction buffer (supplied with the enzyme)
5. 1× bovine serum albumin (BSA) if required by the enzyme
6. Nuclease-free water to final volume (typically 20–50 μL)
7. Incubate at the enzyme's optimal temperature (usually 37°C) for 1–2 hours

1. Verify digestion: Run an aliquot of the digested DNA on an agarose gel to confirm complete digestion. For pBR322, a single cut linearizes the 4,361-bp plasmid, which migrates differently from the supercoiled form.

1. Dephosphorylate the vector (optional but recommended): Treat the digested vector with calf intestinal alkaline phosphatase (CIP) or shrimp alkaline phosphatase (SAP) to remove 5' phosphate groups. This prevents self-ligation of the vector, reducing the background of non-recombinant clones. Use 1 unit of SAP per μg DNA, incubate at 37°C for 30 minutes, then heat-inactivate at 65°C for 15 minutes.

1. Ligate insert and vector: Set up a ligation reaction with a molar ratio of insert to vector of approximately 3:1. A typical reaction:
2. 50–100 ng digested vector
3. Calculated amount of insert (based on size and concentration)
4. 1× T4 DNA ligase buffer (contains ATP and DTT)
5. 1 unit T4 DNA ligase (or 400 units for the concentrated version)
6. Incubate at 16°C for 4–16 hours (overnight ligation is common)

Transformation into E. coli

After ligation, the recombinant plasmids must be introduced into competent E. coli cells:

1. Prepare competent cells: Use chemically competent cells (e.g., DH5α, JM109) prepared by the calcium chloride method, or commercially available high-efficiency cells.

1. Heat-shock transformation:
2. Thaw competent cells on ice (5 minutes)
3. Add 1–10 μL of ligation mixture to 50–100 μL of competent cells
4. Incubate on ice for 30 minutes
5. Heat-shock at 42°C for 45–90 seconds (exact time depends on the strain and protocol)
6. Return to ice for 2 minutes
7. Add 900 μL of pre-warmed SOC or LB broth (without antibiotic)
8. Incubate at 37°C with shaking (200–225 rpm) for 1 hour to allow expression of antibiotic resistance genes

1. Plate transformants: Spread 50–200 μL of the transformation mixture onto LB agar plates containing ampicillin (100 μg/mL). Incubate at 37°C for 16–20 hours.

Screening for Recombinants

The screening process for pBR322 recombinants differs from modern blue-white screening:

1. Primary selection on ampicillin: All transformants carrying pBR322 (recombinant or not) will form colonies on ampicillin plates.

1. Replica plating: Use a sterile toothpick or a replica-plating block to transfer each ampicillin-resistant colony to:
2. An LB agar plate containing tetracycline (15 μg/mL)
3. A master LB agar plate containing ampicillin (100 μg/mL)

1. Interpretation: After overnight incubation at 37°C:
2. Colonies that grow on ampicillin but NOT on tetracycline contain recombinant plasmids with the insert in the tet gene
3. Colonies that grow on both antibiotics contain non-recombinant pBR322 (or recombinants with the insert in a non-tet site)

1. Confirm by restriction analysis: Pick candidate recombinant colonies, grow them in LB broth with ampicillin, isolate plasmid DNA, and digest with the appropriate restriction enzyme to confirm the presence and size of the insert.

Advantages and Limitations of pBR322 as a Cloning Vector

Advantages

• Small size (4,361 bp): pBR322 is small enough to be easily manipulated and purified, yet large enough to accommodate inserts of up to 6–10 kb.
• Dual selectable markers: The presence of both ampicillin and tetracycline resistance genes provides flexibility in selection and enables insertional inactivation screening.
• Moderate copy number (15–20 per cell): This is sufficient for most applications while minimizing metabolic burden on the host.
• Well-characterized sequence: The complete sequence is known, and all restriction sites are mapped precisely.
• Stability: pBR322 is structurally stable and does not undergo rearrangements under standard growth conditions.
• Compatibility: The pMB1 origin allows pBR322 to coexist with plasmids of other incompatibility groups, enabling co-transformation experiments.

Limitations

• No multiple cloning site (MCS): The unique restriction sites are scattered across the plasmid, and not all are flanked by convenient sequencing primers.
• Limited cloning capacity: Inserts larger than 10 kb are difficult to clone due to decreased stability and transformation efficiency.
• Moderate copy number: For applications requiring high yields of plasmid DNA or high levels of gene expression, higher-copy vectors are preferable.
• Insertional inactivation requires replica plating: Unlike blue-white screening, which is faster and more direct, pBR322 screening requires an additional plating step.
• No sequencing primers: pBR322 lacks standardized primer binding sites flanking the cloning regions, requiring users to design their own primers for insert verification.
• Larger than modern minimal vectors: Vectors such as pUC19 (2,686 bp) are smaller and carry an MCS, making them more convenient for routine cloning.

For a broader comparison of vector types, see Cloning Vector in Biotechnology.

Comparison with Other Cloning Vectors

pUC19 is a derivative of pBR322 that was engineered for higher copy number and convenience. The rop gene was deleted, and the tet gene was removed, reducing the size to 2,686 bp. An MCS was inserted into the lacZα gene, enabling blue-white screening. The copy number of pUC19 is 500–700 per cell, making it the vector of choice for routine cloning and plasmid preparation.

pET vectors are designed for high-level protein expression in E. coli. They use the T7 RNA polymerase promoter, which is recognized by T7 RNA polymerase supplied in the host strain (e.g., BL21(DE3)). These vectors are not used for general cloning but for expression of recombinant proteins. See Expression Vector for details.

pGEM-T is a specialized vector for cloning PCR products. It has a single 3'-T overhang at the insertion site, which anneals with the 3'-A overhang added by Taq polymerase during PCR. This is a form of TA cloning, distinct from the restriction-ligation approach used with pBR322.

For specialized applications, vectors such as Topo Cloning Vector Map and Golden Gate Cloning offer alternative strategies that bypass traditional restriction-ligation cloning.

Common Pitfalls and Troubleshooting in pBR322 Cloning

Incomplete Digestion

Problem: The vector is not fully digested, leading to a high background of non-recombinant colonies.

Symptoms: After transformation, nearly all colonies grow on both ampicillin and tetracycline plates, indicating that the tet gene is intact.

Solutions:

• Increase enzyme concentration (2–3× the recommended units per μg DNA)
• Extend digestion time (overnight digestion is acceptable for most enzymes)
• Verify digestion by gel electrophoresis before proceeding to ligation
• Use fresh enzyme and ensure the buffer is appropriate for the enzyme (check for star activity with high glycerol concentrations)

Ligation Efficiency

Problem: Low number of transformants or no colonies at all.

Symptoms: Few or no colonies on the ampicillin plate after transformation.

Solutions:

• Check the molar ratio of insert to vector. A 3:1 insert:vector ratio is optimal. Too much insert can inhibit ligation.
• Ensure the ligase buffer contains ATP (it is labile and degrades with freeze-thaw cycles; prepare fresh aliquots).
• Verify that the insert and vector have compatible ends (both with 5' phosphate or both dephosphorylated appropriately).
• Increase ligation time or temperature (16°C overnight is standard; some ligations work better at 4°C for longer periods).
• Transform more of the ligation mixture (use 5–10 μL instead of 1–2 μL).

Selection Pressure and Satellite Colonies

Problem: Satellite colonies appear around true transformants on ampicillin plates.

Cause: β-lactamase secreted into the medium degrades ampicillin in the vicinity of resistant colonies, allowing non-resistant bacteria to grow.

Solutions:

• Use fresh ampicillin plates (stored at 4°C for no more than 1–2 weeks)
• Increase ampicillin concentration to 100 μg/mL (some protocols use 50 μg/mL, which is less effective)
• Reduce incubation time (satellites appear after 16–20 hours; pick colonies earlier)
• Use carbenicillin (100 μg/mL) instead of ampicillin, as it is more stable

Misinterpretation of Screening Results

Problem: Colonies that grow on ampicillin but not on tetracycline are assumed to be recombinants, but some may be false positives.

Causes:

• The insert may be in a site outside the tet gene (e.g., in the bla gene), in which case the colony would be tetracycline-resistant but ampicillin-sensitive—these would be missed by primary ampicillin selection.
• The tet gene may be inactivated by a deletion or mutation during cloning, not by the desired insert.
• The replica plating may have failed to transfer cells to the tetracycline plate.

Solutions:

• Always confirm candidate clones by restriction digestion and gel electrophoresis
• Perform colony PCR to verify the presence of the insert
• Use a second screening method, such as colony hybridization, if available

Low Transformation Efficiency

Problem: Few transformants even with intact pBR322.

Solutions:

• Check the competence of the cells (transform with a known supercoiled plasmid as a positive control)
• Ensure the heat-shock step is performed at the correct temperature and duration
• Use SOC medium (contains Mg²⁺ and glucose) instead of LB for the recovery step
• Avoid vortexing or excessive pipetting of competent cells

Star Activity of Restriction Enzymes

Problem: Restriction enzymes cut at non-canonical sites, generating fragments of unexpected sizes.

Causes: High glycerol concentration (>5%), incorrect buffer, excessive enzyme, or prolonged incubation.

Solutions:

• Use the recommended buffer and reduce enzyme volume (keep glycerol below 5% of the reaction volume)
• Limit digestion time to 1–2 hours
• Use high-quality, purified enzymes from reputable suppliers

For a comprehensive laboratory reference, consult Molecular Cloning a Laboratory Manual.

Practical Summary and Key Takeaways

pBR322 remains an essential teaching tool and a functional cloning vector for specific applications. Its design principles—compact size, dual selectable markers, and strategic placement of restriction sites—established the paradigm for all subsequent plasmid vectors.

The key mechanism to understand is insertional inactivation: inserting foreign DNA into the tet gene abolishes tetracycline resistance while preserving ampicillin resistance, allowing recombinant clones to be identified by their differential growth on the two antibiotics. This two-step selection strategy is conceptually distinct from the single-step blue-white screening used in modern vectors.

The replication control of pBR322, mediated by RNA I, RNA II, and the Rop protein, is a classic example of antisense RNA regulation. Understanding this mechanism provides insight into how plasmid copy number is maintained and how mutations (such as rop deletion) can dramatically alter plasmid behavior.

Frequently Asked Questions

What is cloning vector pBR322?

pBR322 is a 4,361-bp plasmid cloning vector constructed in 1977 by Bolivar and Rodriguez. It contains an origin of replication from pMB1, an ampicillin resistance gene (bla), a tetracycline resistance gene (tet), and several unique restriction sites located within the resistance genes. It was one of the first engineered cloning vectors and remains a standard teaching tool in molecular biology.

Why is pBR322 considered a good cloning vector?

pBR322 is considered a good cloning vector because it is small (4,361 bp), has a well-characterized sequence, carries two selectable markers (ampicillin and tetracycline resistance), has a moderate copy number (15–20 per cell), and contains multiple unique restriction sites that enable insertional inactivation screening. Its small size facilitates purification and manipulation, while the dual markers provide flexibility in selection.

What is the copy number of pBR322 in E. coli?

The copy number of pBR322 is approximately 15–20 copies per cell under standard growth conditions. This is regulated by the rop gene, which encodes a protein that stabilizes the interaction between RNA I and RNA II, inhibiting replication initiation. In the absence of a functional rop gene (as in pUC19), the copy number increases to 500–700 per cell.

How does insertional inactivation work in pBR322?

Insertional inactivation works by disrupting a gene through the insertion of foreign DNA. In pBR322, if a DNA fragment is inserted into a unique restriction site within the tet gene (e.g., *Bam*HI), the tet gene is inactivated. Transformants are first selected on ampicillin (where all pBR322-carrying cells grow), then replica-plated onto tetracycline. Recombinant clones grow on ampicillin but not on tetracycline, identifying them as containing the insert.

What are the unique restriction sites in pBR322?

The unique restriction sites in pBR322 include *Eco*RI (position 0/4361), *Cla*I (position 23), *Hind*III (position 29), *Bam*HI (position 375, within tet), *Sph*I (position 566, within tet), *Sal*I (position 651, within tet), *Eco*RV (position 187, within tet), *Nhe*I (position 229), *Pst*I (position 3609, within bla), *Sca*I (position 3846, within bla), and *Pvu*I (position 3735, within bla).

What is the difference between pBR322 and pUC19?

pUC19 is a derivative of pBR322 that is smaller (2,686 bp vs. 4,361 bp), has a higher copy number (500–700 vs. 15–20 per cell), and contains a multiple cloning site within the lacZα gene for blue-white screening. pUC19 lacks the rop gene and the tet gene, carrying only ampicillin resistance. pUC19 is generally more convenient for routine cloning, while pBR322 is preferred when moderate copy number or dual selection is required.

How do you select bacteria that have taken up pBR322?

Bacteria that have taken up pBR322 are selected by plating on LB agar containing ampicillin (100 μg/mL). Only cells carrying the plasmid express β-lactamase and can survive. For screening recombinants, colonies are then replica-plated onto tetracycline-containing medium (15 μg/mL) to identify those with an insert in the tet gene.

What is the role of the rop gene in pBR322 replication?

The rop gene encodes the Rop protein (also called Rom), which negatively regulates plasmid copy number. Rop binds to the RNA I-RNA II duplex and stabilizes it, preventing RNA II from forming the persistent RNA-DNA hybrid required for replication initiation. This reduces the frequency of replication, maintaining the copy number at 15–20 per cell. Deletion of rop (as in pUC19) results in uncontrolled replication and high copy number.

Key Takeaways

• pBR322 is a 4,361-bp plasmid with an origin of replication, bla (ampicillin resistance), tet (tetracycline resistance), and unique restriction sites within the resistance genes.
• The copy number of pBR322 is 15–20 per cell, regulated by the rop gene and the RNA I/RNA II antisense control system.
• Insertional inactivation is the key screening mechanism: inserting DNA into the tet gene abolishes tetracycline resistance while preserving ampicillin resistance.
• Selection is performed in two steps: primary selection on ampicillin, followed by replica plating onto tetracycline to identify recombinants.
• pBR322 replicates via the theta mechanism, initiated by RNA II priming and regulated by RNA I antisense RNA and the Rop protein.
• Compared to modern vectors like pUC19, pBR322 has a lower copy number, lacks an MCS, and requires replica plating for screening, but offers dual selectable markers and greater structural stability.
• Common pitfalls include incomplete digestion, poor ligation efficiency, satellite colonies from β-lactamase secretion, and misidentification of recombinants; these can be addressed by optimizing enzyme conditions, using fresh antibiotics, and confirming clones by restriction analysis.

Further Reading

• Boros I, Pósfai G, Venetianer P. High-copy-number derivatives of the plasmid cloning vector pBR322. Gene. 1984. PubMed 609622090130-6)
• Balbás P et al. Plasmid vector pBR322 and its special-purpose derivatives--a review. Gene. 1986. PubMed 303473590307-0)
• Prentki P, Krisch HM. A modified pBR322 vector with improved properties for the cloning, recovery, and sequencing of blunt-ended DNA fragments. Gene. 1982. PubMed 628271390072-5)
• Edwards DR, Parfett CL, Denhardt DT. A pBR322-derived vector for cloning blunt-ended cDNA: its use to detect molecular clones of low-abundance mRNAs. DNA (Mary Ann Liebert, Inc.). 1985. PubMed 3865759
• Lacks SA, Greenberg B. Sequential cloning by a vector walking along the chromosome. Gene. 1991. PubMed 165557490458-n)
• Zimmermann W et al. Molecular cloning of the hamster papovavirus genome in Escherichia coli plasmid vector pBR322. Gene. 1984. PubMed 609222690184-7)

Related Clinical & Scientific Guides

• MAPK Pathway: Mechanism, Function, and Clinical Relevance
• Mammalian Cell Culture Bioreactors: A Practical Guide
• Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks